Dr. Alina Allen has a clinical and research interest in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis (NASH). She is interested in early diagnosis using non-invasive measures, testing novel treatments via clinical trials, management of complications including end-stage liver disease requiring evaluation for liver transplantation, as well as long-term care of liver transplant recipients.